While cerebellar alterations may play a crucial role in the development of core autism spectrum disorder (ASD) symptoms, their pathophysiology on the function of cerebrocerebellar circuit loops is largely unknown. We combined multimodal MRI (9.4 T) brain assessment of the prenatal rat valproate (VPA) model and correlated immunohistological analysis of the cerebellar Purkinje cell number to address this question.
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Introduction
Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder 1 , currently diagnosed using behavioral tests that can be subjective; therefore, objective noninvasive imaging biomarkers of autism are being actively researched [2] [3] [4] [5] .
Cerebrocerebellar circuit dysfunction may play a crucial role in the etiology of ASD, as cerebellar lesions or structural and functional differences in various cerebellar subregions consistently have been linked to ASD [6] [7] [8] [9] [10] [11] . MRI findings of the cerebellum in ASD, however, remain less clear 12 : although the size of the vermis appears to be slightly smaller and structural differences in cerebellar lobule VII (right crus I/II) are associated with core ASD symptoms and may have potential functional impact 6, 7 . Similarly, the great majority of a substantial number of postmortem anatomical studies of ASD show decreased Purkinje cell density, but with focal regional alterations 6, 13 .
Neuroanatomical studies underline the extensive and region-specific connectivity between the cerebellum and the cerebral cortex with two-stage feed-forward and feed-back loops, e.g., lobules VI/VII (crus I/II) of the cerebellum are linked with the association areas of the cerebral cortex concerned with higher order behavior, such as the prefrontal cortex, posterior parietal cortex or cingulate gyrus 14, 15 . The anterior part of the cerebellum has a sensory domain, in addition to its traditionally known role in motor functions, and the posterior part of it contributes to some aspects of affective and cognitive processing [16] [17] [18] .
Indeed, cerebellar posterior lobe lesions define cerebellar cognitive affective syndrome (CCAS), and in utero or early postnatal lesions induce behavioral and social deficits that overlap with ASD symptoms 15, 19 .
Despite these seminal findings highlighting the potential functional impact of disrupted cerebrocerebellar loops in ASD 8, 20 , fundamental questions about the pathophysiology of these cerebrocerebellar loops have remained unanswered. Equally, their translational utility is unknown, limiting the progress in pursuing objective neuroimaging biomarkers in ASD.
We addressed these questions by combining multimodal neuroimaging and correlated immunohistological analysis of the cerebellar Purkinje cell number in a prenatal rat valproate (VPA) model. We hypothesized that our functional MRI (fMRI) paradigm might show some altered activity related to disrupted cerebrocerebellar information processing. We used a somatosensory functional fMRI paradigm suitable for small animal imaging. Our paradigm, by involving nested loops of the whisker system at the cerebellar, midbrain and thalamocortical level 21 , allocates reasonable translational power to sensory-attentional paradigms in human studies. To ensure that our findings are unspecific to any developmental phase, we performed an MRI assessment of the same cohort twice, with a one-month difference (measurement 1 and 2). Furthermore, due to the uncertainty regarding the optimal maternal VPA dose, in addition to a control group with maternal vehicle treatment, we investigated two VPA groups, with maternal doses of 400 mg/kg and 600 mg/kg (hitherto referred to as the VPA400 and VPA600 groups).
Results

Valproate-induced reduction of cerebellar gray matter and whole brain volume
Because both human ASD and its VPA model are known to present specific morphological features, our first assessment was to perform volumetry and voxel-based morphometry (VBM) analysis on the structural MRI scans. Anatomical scans at measurement 1 revealed that prenatal exposure to VPA resulted in 3.2% smaller whole brain volume in the VPA600 group (p=0.006, effect size: -81.1 mm 3 ) compared to controls. Smaller brain size was also observed in gray matter (-3.2%, p=0.02, effect size: -52.7 mm 3 ) and white matter (-2.4%, p=0.09, -13.2 mm 3 ) volume; however, the latter was not significant. A milder difference in the whole brain volume (-2%, p=0.06, effect size: -51.9 mm 3 ) was observed in the VPA400 group, and this was not detectable either in the gray or in the white matter volume. Detailed summary statistics of the volumetry data are listed in Supplementary Table 2. VBM analysis of the structural MRI scans was used to localize the whole brain averaged gray matter volumetric differences. In the VPA600 group, the VBM analysis could not detect any well-localized source of the smaller global gray matter volume; there were no normalized voxels showing significantly lower gray matter density (signal intensity modulated by Jacobian determinants) compared to the vehicle group. On the other hand, significantly lower focal gray matter density was observed in the VPA400 group in various brainstem nuclei and the bilateral cerebellar crus I/II and paraflocculus compared to controls (Fig. 1 ).
Comparing the VPA400 and VPA600 groups revealed a highly similar pattern of localized focal hypoplasia in the VPA400 group, suggesting that this cerebellar and brainstem gray matter difference is specific to the 400 mg/kg prenatal dose. No positive differences in gray matter density were observed in either of the VPA groups compared to the VEH group. Evidence of cerebellar (crus I/II and paraflocculus) and brainstem (lemniscus) gray matter hypoplasia was observed only in the VPA400 group compared to both the VEH (top) and the VPA600 (bottom) groups (measurement 1).
Compared to the VEH group, no decreases in VPA600 group and no increases in either of the VPA groups were observed. These results, together with the tissue volumetry analysis (Fig. 3) , suggest that the 400 mg/kg VPA dose might be in an appropriate range for triggering autistic-like morphological features, as opposed to the 600 mg/kg dose, which in turn exhibits cortical hypoplasia without cerebellar alteration. 
BOLD response to whisker stimulation
We assessed the possible ASD-related functional changes in the VPA rat model in the sensory domain by somatosensory stimulation-based functional MRI. Whisker stimulation evoked a widespread, significant BOLD response in all three animal groups (Supplementary   Tables 3-5 , Fig. 2A ). As expected, the activation peaked in the barrel field of the primary somatosensory (S1) cortex (contralateral to the stimulation side) and in a blob covering the primary auditory (Au1) and the secondary somatosensory (S2) cortices. The group-mean maximal signal change in S1 was 0.36%, 0.68% and 0.34% in the VEH, VPA400 and VPA600 groups, respectively. The ipsilateral somatosensory activation was weaker but also significant in all three groups. Additionally, bilateral striatal, frontal, orbitofrontal, insular, entorhinal, cerebellar, and amygdalar as well as brainstem (trigeminal) activations were found in all three groups. Local maxima and effect sizes are reported in Supplementary   Tables 3-5 . In general, group-level activation was the most extended in the VPA400 group (455.8 mm 
Functional hyperactivation as a consequence of prenatal valproate exposure
Between-group fMRI analysis contrasts revealed that several of the striking differences of the groupwise activation patterns were statistically significant (Fig. 2B , Table 1 ). A remarkable and robust effect of prenatal VPA exposure was the widespread increase in the BOLD response to whisker stimulation (Fig. 2B , Table 1 ). In both the VPA400 and VPA600 groups, pronounced hyperactivation was found in the primary somatosensory, ventral orbital, anterior cingular and frontal association cortices. No decreased activation was detected in either of the VPA groups.
Contrasting the VPA400 and VPA600 groups revealed stronger hyperactivation in the VPA400 group, especially in regions of the primary somatosensory (contralateral to stimulation), ventral orbital, and frontal association cortices ( ).
The VBM analysis of measurement 2 demonstrated decreased gray matter density in cerebellar and brainstem locations of the VPA400 group with a remarkable overlap with measurement 1 (Fig. 3F ). The decrease was also observed in contrast to the VPA600 group, while there was no change in gray matter density in any other group contrast.
In measurement 2, the group-level spatial pattern of whisker stimulation-induced BOLD activations were similar to those of measurement 1 ( Supplementary Fig. 1 .), although with smaller magnitudes due to the higher isoflurane doses. This and the smaller sample size due to exclusions (e.g., in-scanner motion; N=33) resulted in a decreased statistical power.
Nevertheless, we were still able to detect functional hyperactivation in the VPA400 group compared to the vehicle group. The hyperactivation was significant in a cluster in the primary somatosensory cortex (contralateral to stimulation, cluster-level correction for multiple comparisons, P clust =0.045, clusterwise mean increase in effect size: 0.28%, see
Supplementary Fig. 2 and Fig. 3 ).
As mentioned above, due to the greater weight of the animals at measurement 2, more isoflurane was needed to maintain a comparable level of anesthesia and respiration rate (Supplementary Table 1 ). Since the vasodilatory action of high isoflurane doses has an unfavorable effect on the magnitude of BOLD responses 22 , direct comparison or pooling of the measurements would be inappropriate. Therefore, we regard measurement 2 merely as a confirmatory measure. 
Decreased cerebellar Purkinje cell number revealed by calbindin D28k immunostaining
Because lower Purkinje cell density is one of the most reproduced cerebellar postmortem anatomical findings in ASD, we made calbindin D28k (CB) immunostained sagittal sections from the cerebellums of 27 rats (9 from each group). We found that the number of CBpositive Purkinje cells was significantly lower in both VPA groups compared to the VEH group (Fig. 4 ) in all lobules tested (6a, 6b, 6c, 7). The difference was a larger magnitude in the VPA400 
Correlation of the BOLD response with the cerebellar Purkinje cell number
To the best of our knowledge, it is not known how lower Purkinje cell number is related to abnormal brain function in the VPA-model of ASD. Here, we analyzed how the correlation of individual Purkinje cell number and BOLD response to somatosensory stimulation is related to prenatal VPA exposure. In the VPA400 group (in animals with histological data available), a significant positive correlation of BOLD response with cerebellar Purkinje cell number was found in the frontal and cerebellar areas (Fig. 5B, Supplementary Table 10 ). In contrast, the VPA600 group exhibited a significant negative correlation in cortical and cerebellar regions (Fig. 5C, Supplementary Table 11) . No significant correlation was found in the control group (Fig. 5A ). 
Interaction effect of cerebellar Purkinje cell number and valproate treatment on the cerebellar and cerebral BOLD response
To capture VPA exposure-related effects, the differences in the groupwise "BOLD-Purkinje" correlation maps were further investigated by an interaction analysis. This revealed that the regression slopes between BOLD response and Purkinje cell number in the medial frontal cortex and in a small cerebellar region are significantly larger in the VPA400 group than in the vehicle group (Fig. 5D) . We also observed areas of significant interaction in the VPA600
group. Here, the interaction coefficient was negative, implying that the regression slopes between BOLD response and Purkinje cell number in some cerebellar and somatosensory regions are significantly smaller (in fact, more negative) in the VPA600 group than in the vehicle group (Fig. 5D ). The significant cerebral interaction between VPA treatment and Purkinje cell number suggests a VPA-induced cerebrocerebellar malfunction that is unseen when only focused on the cerebellum.
To gain a more direct insight into the treatment x Purkinje interaction effect on BOLD response, we conducted an ROI analysis. We defined two unbiased ROIs and investigated the No such correlation was observed in the VPA600 group; however, the values might represent the naturally continuing trajectory of the relationship seen in the VEH group, but in ranges of the lower Purkinje numbers, where the BOLD response already converges to zero. In contrast, the strong positive correlation in the VPA400 display no continuity to the VEH group. In this case, despite the remarkable decrease in Purkinje cell number, the BOLD responses were comparable to those of the controls. . While a few reports have already examined cerebellar anomalies in the prenatal VPA rat model 28, 29 , the relationship of the abnormal Purkinje cell number to the function of cerebrocerebellar circuitry has not yet been investigated.
ASD-like cerebral and cerebellar structural changes
In our study, brain hypoplasia was globally detected in the VPA600 group. In preclinical studies, even higher prenatal dose regimens are often used with similar results 29, 30 ; however, the observed magnitude of whole brain volume differences might be somewhat severe. On the other hand, the smaller dose (VPA400 group) by still inducing a focal, cerebellar gray matter difference (Fig. 1 ) might be in an appropriate range for triggering autistic-like morphological features without causing severe hypoplasia. Moreover, cerebellum-specific morphometric alterations, which could be a signature of human ASD, were only detected with this prenatal dose. These morphometric alterations localized in the cerebellar crus I/II and paraflocculus (in both measurements) compared to the VEH control group and the VPA600 group. The paraflocculus could be involved in atypical gaze 31 , the posterior cerebellar vermis (vermal lobules VI-VII) and right crus I in repetitive behaviors and stereotyped interests in ASD 32 . Crus I/II abnormalities are related to more severe ASD impairments in all domains 7 with altered functional connectivity to specific cerebral regions 11, 33, 34 .
Our structural MRI findings in this model may contradict the widely known "early brain overgrowth" phenotyping efforts in ASD [35] [36] [37] , although increases in brain volume in high-risk infants may co-occur with excessive extra-axial cerebrospinal fluid (CSF) 5 . Nonetheless, several studies have suggested divergent age effects on brain morphology changes in ASD 36 , with a more rapid age-related cortical thinning in temporal and parietal regions compared to controls 38 . Decreased thickness in the temporal cortex was reported recently from a large multinational sample of the ENIGMA ASD working group, while at the same time, increased cortical thickness in the frontal cortex was found 39 . Similarly, using data from the multicenter repository, the ABIDE initiative, a surface-based cortical thickness analysis revealed an increase in prefrontal cortical thickness in ASD 40 . Remarkably, an inverse correlation had been found earlier between the sizes of the frontal lobe and cerebellum in ASD 41 , reflecting an abnormal overgrowth in the frontal lobes 42 .
Sensory BOLD hyperactivation induced by prenatal valproate exposure
Sensory abnormalities are known in ASD (DSM-5, diagnostic criteria B.4.) Somatosensory evoked potentials show hyperactivity in infantile autism 43 as in Fmr1(-/y) mice 44 ; therefore, sensory hypersensitivity may have translational value. Prenatal VPA rats have also shown increased sensory reactivity to mechanical stimuli 45 and increased neuronal activation in the auditory brainstem after sound exposure 46 . Interestingly, local functional overconnectivity was not demonstrated in the somatosensory cortex of ASD individuals by magnetoencephalography, challenging the theory that the primary substrate of hypersensitivity is localized in the somatosensory cortex 47 .
In our fMRI measurement, the presence of altered sensory processing was reinforced in the prenatal VPA model of autism. The BOLD hyperactivation was more pronounced in the VPA400 group, but it was also clearly present in the VPA600 group. BOLD hyperactivation was prominent in areas with a significant group-mean response in the VEH group, and frontal hyperactivation, including the lateral and ventral orbital, prelimbic, frontal association, and anterior cingular cortices, was also found in the VPA groups. In the VPA400 group, there were additional activations in the brainstem and cerebellar regions (specifically in the crus II); however, these activations proved to be significant only when compared to the VPA600 group.
Although both the hypoplasia found in our VBM analysis and the cerebellar hyperactivations in the VPA400 group were localized in nonsensorimotor areas of the cerebellum (paraflocculus and crus I/II), a direct link of structural changes to the observed sensory hyperactivation might also be possible, since there is evidence for a noncanonical organization of cerebrocerebellar circuits in ASD, especially in the sensory domain 48, 49 . Since the paraflocculus has projections to the brainstem and the crus I/II normally interconnects with frontal and parietal areas, the brainstem (lemniscus) and frontal components of the BOLD hyperactivation might also reflect the consequences of noncanonically organized cerebrocerebellar circuits. Consistent with this interpretation, abnormal cortical connectivity of the crus I/II region has been found in ASD 7, 8, 11 .
Atypical effect of decreased Purkinje cell number on cerebrocerebellar activity
Following current ideas about the atypical functional connectivity of cerebrocerebellar circuit loops in ASD 7, 8, 48, 49 , it is straightforward to hypothesize that the significant VPAinduced decrease in Purkinje cell number might have a developmental effect on the cerebral cortical regions the cerebellum functionally connected with 8, 20 . We addressed this assumption by testing the groupwise correlation of BOLD response and Purkinje cell number and whether it was different between groups (evaluating the "treatment x Purkinje cell number" interaction effect on the BOLD response).
In the case of the cerebellar BOLD signal, the main contributor to the activity is the parallel / mossy fiber system 50 , and the contribution of the Purkinje cell activity might be relatively small 51 . Therefore, instead of simply reflecting the summed activity of Purkinje cells, the positive correlation between BOLD response and Purkinje cell number observed in the control group might be driven by the indirect effect of increased cerebral input through the parallel / mossy fiber systems.
On the other hand, throughout the cerebral activation areas, the BOLD -Purkinje cell number correlation is negative in the control group, which might be either a consequence of a stronger modulatory / inhibitory effect in the presence of more Purkinje cells or might be caused by some neurodevelopmental source affecting both Purkinje cell development and the maturation of distant cerebral circuits. Indeed, on the Purkinje cell level, prenatal VPA exposure delayed the developmental excitatory / inhibitory GABA ''switch'' 52 , supporting a role of developmental timing in the pathophysiology of ASD.
The correlation of the BOLD response and Purkinje cell number is strongly dependent on the dose of VPA exposure. The simplest explanation for the significant "group x Purkinje cell number" interaction in the VPA600 group is that they represent a naturally continuing, nonlinear trajectory of the VEH group but in ranges of significantly lower Purkinje cell numbers, where the BOLD response already saturates to zero (thereby introducing a difference in linear regression slopes; also visible in Fig. 6 ). However, this explanation does not hold for the VPA400 group. Here, our results suggest that, despite the lower Purkinje cell numbers, the BOLD-Purkinje correlation maintained at similar or even higher levels than those of the control group, possibly by means of some compensatory mechanisms. 
Gestational valproic acid administration
The timed-pregnant female Sprague-Dawley rats received a single subcutaneous dose of 400 or 600 mg/kg sodium VPA (Sigma-Aldrich Chemical Co, UK) or vehicle (saline injection) in the loose skin area of the neck in a volume of 1 ml/kg dissolved in sterile physiological saline at gestational day 12.5 as described previously 53 . The treatment groups are referred to as VEH, VPA400 and VPA600. On postnatal day 21, male offspring were weaned and housed in groups of 3 or 4.
Image acquisition
Before magnetic resonance imaging, animals were habituated to the acoustic noise of the MRI scanner for 1 week in a separate animal room. In the experiments, 36 male rats (12 rats from each treatment group) were used. The mean (± standard deviation) initial weight of the rats was 209 (±27) g over the first MRI measurements (performed in a period of two weeks) and 393 (±23) g over the second MRI measurements (beginning one month after the end of the first measurement). Four rats were scanned per day in a random order from each treatment group.
On the day of scanning, rats were anesthetized before transporting to the magnet room.
Anesthesia was introduced with 5% isoflurane and then maintained at approximately 1.25% during scanning. The body temperature was maintained at 38±1°C with thermostatically controlled air flow around the rat. The respiration of the animal was monitored continuously with a small pneumatic pillow sensor during the experiment (SA Instruments, Inc., NY, USA).
The MRI experiments were performed using a 9.4 T Varian MRI system (Varian Associates Inc., Palo Alto, CA) with a free bore size of 210 mm, which contained a 120 mm inner size gradient coil (minimum rise time 140 μs; 200 μs were used). For excitation, an actively RFdecoupled 2 channel volume coil system with an inner size of 70 mm was used, and a fixedtuned receive-only phase array rat brain coil (RAPID Biomedical GmbH, Rimpar, Germany) was located directly above the dorsal surface of each rat's head to maximize the signal-tonoise ratio.
For the spatial coregistration of fMRI scans and for voxel-based morphometry (VBM), proton density weighted anatomical scans were acquired using gradient echo multi-slice imaging 
MRI measurements: anesthesia, respiration and motion
Since motion artifacts are very problematic in MRI, before any further analysis, we examined the magnitude and between-group differences in in-scanner motion, respiration and anesthetic dose. Despite the superficial anesthesia during functional MR imaging, motion was moderate throughout all MRI experiments (Supplementary Table 1 ). For both MRI measurements, weight, average in-scanner motion (as estimated by the motion correction algorithm), isoflurane dose and respiration rate were not different between the groups.
Summary statistics of these measures are listed in Supplementary Table 1 .
Functional MRI experiments
The T2*-weighted echo planar imaging (EPI) sequence for the fMRI experiments had the 
Exclusion criteria
Exclusion criteria were fixed prior to data analysis as follows: scans with striking imaging artifacts (based on visual inspection) or with an average root mean squared relative displacement greater than 0.05 mm during the fMRI scan (as calculated by FSL) were subject to exclusion from all analyses.
Moreover, subjects without immunohistological data were excluded from the analyses focusing on the correlation of BOLD response with Purkinje cell number and its group-level interaction.
None of the scans had to be discarded due to artifacts or in-scanner motion issues, resulting in N=36 for the whole-brain fMRI analysis of the first measurement. On the other hand, in the second measurement, 3 animals had to be excluded because of in-scanner motion and inadequate anesthesia (2 controls and 1 in the VPA600 group), resulting in N=33.
The immunohistology experiments were only performed for N=9 animals per group, and one animal from the VPA600 group had to be excluded for technical reasons.
Imaging data analysis
To obtain maximally translatable results, we followed the conventions set for human MRI analysis, similar to our previous works 23, 55 . Small-animal imaging-specific features of the applied image processing pipeline are described in detail. When not specified otherwise, the same data analysis steps were performed in the first and second MRI measurements.
Preprocessing
The raw images were converted to NIfTI-format (Neuroimaging Informatics Technology To achieve spatial correspondence for the group analysis, all images were spatially standardized using FSL FLIRT 60 , which utilized a 6-parameter rigid-body transformation. The high-resolution structural image was fitted to an in-house developed standard template 23 (average of 200 nonlinearly fitted structural images) by an affine transformation (FLIRT) and a nonlinear deformation field estimated by FNIRT 61 . In the latter coregistration procedure, a 10 x 10 x 10 mm 3 warping field (in upscaled space) was estimated with three iterations using a relatively conservative lambda parameter set of 60, 40 and 20. This stricter regularization was applied as the morphological diversity of the rat brain is smaller compared to humans.
Voxelwise functional MRI (fMRI) analysis
Before the statistical analysis, the functional images were spatially smoothed using a
Gaussian kernel of 12.0 mm FWHM (note that the images were upscaled). High-pass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma=140.0 s) was then applied to remove slow drifts from the signal. The fMRI data processing was . Individual statistical Z-score images for the first regressor were obtained (average BOLD response to the stimuli).
Using the spatial transformations computed during image coregistration and standardization, Z-score maps resulting from the individual statistical analysis were realigned to the common standard space to achieve spatial correspondence during the group-level voxelwise analysis.
A second-level general linear model analysis was performed with FEAT. Data from the first and second measurements were analyzed separately. Three different statistical models were evaluated for both measurements.
Model 1 was a simple model with three explanatory variables modeling the treatment groups with dummy coding (N=36 and 33 for measurement 1 and 2, respectively). Statistical contrasts were defined to assess the VPA400 vs. VEH., VPA600 vs. VEH and VPA400 vs.
VPA600 comparisons. An F-contrast was also specified to establish a statistical map of voxels activated in at least one of the three groups. This map was used for defining unbiased ROIs.
Model 2 was a model analogous to Model 1 but with the restricted population for which histological data were also available (N=25, for both measurements). The goal of this model was simply to demonstrate that the results of model 1 are not driven by animals excluded from further analysis (that is, the restricted population is still representative in terms of findings in the whole population). The resulting group-level statistical maps were corrected for multiple comparisons on the voxelwise-level, with a GRF-theory-based maximum height thresholding procedure and thresholded with a significance threshold of P=0.05 64 . For the second measurement, a cluster-based thresholding was also applied, with a Z=3.1 cluster-forming threshold and a cluster probability cutoff of P=0.05. This thresholding method, although less effective in localizing the activation, was used because the voxelwise thresholding was too conservative for the observed lower effect sizes in the group-contrast images of measurement 2.
ROI analysis
In addition to voxel-based analyses, a cerebral and cerebellar ROI was defined, and the individual ROI-mean percent BOLD signal change was calculated and compared between groups. These ROIs were delineated based on the unbiased F-contrast of Model 1 to avoid favoring any of the groups. This activation map was thresholded with a GRF theory-based maximum height thresholding procedure and thresholded with a significance threshold of P=0.05 to identify voxels that were activated in at least one of the groups. The resulting activation mask was than multiplied by in-house cerebellum and cerebrum masks to define the cerebellar and cerebral ROIs of activation, respectively. These were used for the ROIlevel interaction analysis (Fig. 6) .
MRI volumetric and voxel-based morphometry analysis
We used the voxel-based morphometry (VBM)-style protocol 65 of FSL 59 , but optimized for the rat brain, as in our previous study 55 . Nonbrain parts were removed from all the structural images 59 , and tissue-type segmentation was carried out by FAST4 66 . To obtain optimal tissue classification, an in-house a priori tissue map 55 was used. The volume of whole-brain gray and white matter was estimated by taking the sum of the corresponding partial-volume estimate maps.
The resulting gray-matter partial volume images were registered to a standard space using linear transformation 58 , followed by a nonlinear registration 61 . The resulting images were averaged to create a study-specific template, to which the native-space gray matter images were then nonlinearly reregistered. The registered partial volume images were then modulated (to correct for local expansion or contraction) by being divided with the Jacobian of the warp field (incorporating the linear scaling factor, as well). The modulated segmented images were then smoothed with an isotropic Gaussian kernel with a sigma of 4 mm. Finally, statistical inference on the treatment effect was performed by voxelwise GLM with permutation-based nonparametric testing (FSL's randomise). Cluster-based belief-boosting was carried out by the TFCE technique 67 . The images were then thresholded with permutation-based empirical maximum height thresholding at a (corrected) significance threshold of P=0.05 64 .
Histological processing
Perfusion and preparation of tissue sections
The animals were deeply anesthetized using intraperitoneal injection of an anesthetic mixture (containing ketamine, xylazine hydrochloride, promethazinium chloride) and perfused through the heart first with saline (2-3 min) followed by a fixative (30 min) containing 4% paraformaldehyde in 0.1 M phosphate buffer (PB) (pH 7.4). Brains were removed from the skull. After vibratome slicing and extensive washing in 0.1 M PB, the 60 μm-thick sections were incubated in 30% sucrose overnight, followed by freeze thawing over liquid nitrogen four times.
Immunocytochemistry
The sections were processed for immunoperoxidase staining. All washing steps and dilutions of the antibodies were performed in 0.05 M Tris-buffered saline (TBS), pH 7.4. After extensive washing in TBS, the sections were blocked in 3% bovine serum albumin for 45 min and then incubated in rabbit anti-calbindin-D28kD antibody (1:1000, Swant) for a minimum of 48 h at 4°C. Following the primary antisera, the sections were treated with biotinylated anti-rabbit IgG (1:300) raised in goat for 2 h and then with avidin biotinylated horseradish peroxidase complex (1:500; Elite ABC; Vector Laboratories) for 3 h at room temperature. The immunoperoxidase reaction was developed using 3,3'-diaminobenzidine (DAB) as the chromogen.
Statistical analysis of brain volumetry, ROI and histological data
Gray and white matter volumetry, cerebral and cerebellar ROI and lobule-wise histological data were compared by means of permutation testing to overcome possible normality issues. Permutation-based linear models (R-package lmPerm) were fitted to explain these data with a factor variable representing the treatment groups. Additionally, for the interaction analysis of the cerebral and cerebellar ROIs, the demeaned, normalized Purkinje cell number of the cerebellar lobe 7, and its interaction with the group factor variable was also added.
The number of maximum permutations was set to 100000, and factor variables were explicitly set to be handled with the "treatment" contrast of R (traditional "dummy coding").
Permutations were stopped when the estimated standard error of the estimated p was less than 0.01*p.
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